Title: Phase I trial of SU14813 in patients with advanced solid malignancies.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology 20110101
Title: Evaluation of CXCR4 inhibition in the prevention and intervention model of laser-induced choroidal neovascularization.
Journal: Investigative ophthalmology & visual science 20100701
Title: Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia.
Journal: Blood 20070915
Title: SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity.
Journal: Molecular cancer therapeutics 20060701
Title: Patyna S, et al. SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity. Mol Cancer Ther. 2006 Jul;5(7):1774-82.